Clinical Trial Update: Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing oral pilocarpine (Salagen) to a submandibular salivary gland transfer protocol for preventing radiation-induced xerostomia in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Salagen (pilocarpine) (pilocarpine)

Snippet

Sponsor: Alberta Health services | Conditions: Cancer, Head and Neck Cancer | Phase 3 | Status: COMPLETED